This study is looking at how a test called Onco4D® Biodynamic Chemotherapy Selection Assay helps doctors choose chemotherapy for cancer patients. Many people with cancer receive chemotherapy that can have side effects without always helping. The Onco4D® test aims to predict how a patient's tumor will respond to different chemotherapy drugs before treatment starts. Researchers want to see if using this test leads to better outcomes, specifically if more patients achieve a pathologic complete response (pCR), meaning no signs of cancer are found after treatment. You can join if you have any type of cancer, are at least 18 years old, and your doctor has ordered the Onco4D® test.

Study design

This is an observational study, meaning researchers will watch and collect information about patients who receive the Onco4D® test. It aims to include 1000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Researchers will follow up to measure pathologic complete response (pCR) at 1 year, and event-free survival at 2 and 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.